Intercellular communication is essential in bone remodelling to ensure that new bone is formed with only temporary bone loss. Monocytes (MCs) and osteoclasts actively take part in controlling bone remodelling by providing signals that promote osteogenic differentiation of mesenchymal stem/stromal cells (MSCs). Extracellular vesicles (EVs) have attracted attention as regulators of bone remodelling. EVs facilitate intercellular communication by transferring a complex cargo of biologically active molecules to target cells. In the present study, we evaluated the potency of EVs from MCs and osteoclasts to induce a lineage-specific response in MSCs. We analysed gene expression and protein secretion by both adipose tissue-derived MSCs and bone marrow-derived MSCs after stimulation with EVs from lipopolysaccharide-activated primary human MCs and (mineral-resorbing) osteoclasts. Isolated EVs were enriched in exosomes (EVs of endosomal origin) and were free of cell debris. MC-and osteoclast-derived EVs were taken up by adipose tissue-derived MSCs. EVs from activated MCs promoted the secretion of cytokines by MSCs, which may represent an immunomodulatory mechanism. MC-derived EVs also upregulated the expression of genes encoding for matrix metalloproteinases. Therefore, we hypothesize that MCs facilitate tissue remodelling through EV-mediated signalling. We did not observe a significant effect of osteoclast-derived EVs on gene expression or protein secretion in MSCs. EV-mediated signalling might represent an additional mode of cell-cell signalling during the transition from injury and
Introduction
Cells release diverse types of membrane vesicles into the extracellular environment. These so-called extracellular vesicles (EVs) represent an important mode of intercellular communication by transferring a complex cargo of biologically active molecules to target cells [1, 2] . Given the importance of cellular interactions in bone remodelling [3] , EVs have attracted attention as regulators of this process [4] . EVs could find use in the treatment of bone diseases that are related to aberrant bone remodelling, such as rheumatoid arthritis, osteoarthritis and osteoporosis [5] . Moreover, EVs have potential in regenerative medicine as biomimetic tools to induce lineagespecific differentiation of stem cells [6, 7] . The cell type from which the most potent regulatory EVs originate and the mechanism by which the EVs mediate bone remodelling remain to be investigated [5, 8] .
The immune system strongly influences tissue repair and regeneration, and active control of the immune system is an attractive therapeutic approach to induce tissue regeneration [9] , including bone regeneration [10] . The mononuclear phagocytic system is part of the immune system and consists of hematopoietic cells derived from progenitor cells in the bone marrow (BM) [11] . Monocytes (MCs) and osteoclasts (OCs) are mononuclear phagocytic cell types that share precursors. Both MCs [12, 13] and OCs [14] [15] [16] actively take part in controlling bone remodelling by providing signals that promote osteogenic differentiation of mesenchymal stem/stromal cells (MSCs).
In the context of tissue healing, there are few studies looking into the potential of EVs from mononuclear phagocytes. Nevertheless, EVs from these cells most likely have a role in the crosstalk between immunity and tissue healing [17] and may contribute to maintaining bone homeostasis [4] . In the present study, we evaluated the potency of EVs from primary human MCs and OCs to induce a lineage-specific response in MSCs. We analysed gene expression and protein secretion by both adipose tissue-derived MSCs (AT-MSCs) and BM-derived MSCs (BM-MSCs) after stimulation with EVs from activated primary human MCs and OCs. The study sheds light on the mechanism by which EVs mediate bone remodelling and their potential as therapeutic tools to enhance the regeneration of bone tissue.
Results

Culture of lipopolysaccharide-activated monocytes and formation of osteoclasts on tissue culture plastic and hydroxyapatite coatings
Monocyte and OC cultures were monitored using a phase-contrast microscope (Fig. 1) . Lipopolysaccharide (LPS)-activated MCs were visible as small adherent cells. The conditioned medium from these cells was collected at 3 days (Fig. 1A ,B) and 5 days (Fig. 1C ) of culture. Part of the LPS-activated MCs was positive for OC-marker tartrate resistant acid phosphatase (TRAcP; Fig. 1B) .
One of the aims of this study was to investigate the effect of OC-EVs on the differentiation of MSCs. Therefore, peripheral blood MCs were differentiated towards OCs using macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor j-B ligand (RANKL). MCs eventually fused and formed OCs in presence of M-CSF and RANKL (Fig. 1D,E) . Nonactive OCs were generated on tissue culture plastic (tissue culture polystyrene, TCPS). Henriksen et al. [16] showed that pro-osteogenic signalling of OCs is partially dependent on mineral dissolution. To investigate if the potential EV-signalling from OCs to MSCs is dependent on mineral dissolution, cells were also cultured on a hydroxyapatite (HA) substrate ( Fig. 1H-K) . HA coatings have been previously used to model mineral dissolution by OCs [18, 19] . The formation of mature OCs was confirmed by the positive staining for TRAcP (Fig. 1F) . Mature OCs on HA were dissolving the substrate (Fig. 1K,J) . characterized for size, morphology and the presence or absence of membrane proteins. Transmission electron microscopy revealed the isolation of vesicles with an intact lipid bilayer ( Fig. 2A-F) .
Nanoparticle tracking analysis showed that the large majority (> 80%) of the particles isolated in this study was between 50 and 200 nm in diameter (Fig. 3) . The number of particles between 50 and 400 nm in diameter were considered EVs for the functional assays in this study. Isolation using the kit resulted in a higher number of EVs than isolation by UC (Table 1) , especially from OCs cultured on TCPS. The number of EVs recovered from MC-conditioned medium by UC did not reach beyond the background levels of unconditioned LPS-supplemented medium. UC yielded bigger EVs, especially for MCs.
Western blotting revealed the presence of EVassociated proteins CD90 (Thy-1), tumour susceptibility gene 101 (TSG101) and 70 kilodalton heat shock proteins (Hsp70; Fig. 4 ). TSG101 and Hsp70 were also detected from MC lysate. CD63 (lysosomal-associated membrane protein 3), a marker for EVs of endosomal origin was only barely detectable extracellular vesicles from lipopolysaccharide-activated MCs (MC-EVs). CD63 was on the other hand highly enriched in EVs from OCs cultured on both TCPS (OC TCPS-EVs) and HA coatings (OC HA-EVs). MC and macrophage marker CD14 was present in all EV types, just like RANKL receptor RANK. The CD14 and RANK signals were minute in MC lysate. Calnexin, a protein of the endoplasmic reticulum, was only present in MC lysate.
Uptake of EVs by adipose tissue-derivedmesenchymal stem/stromal cells
To show that the MC-EVs and OC-EVs could interact with MSCs, we studied the uptake of the EVs by ATMSCs (Fig. 5 ). EVs were labelled with lipophilic dye DiD before adding them to AT-MSC cultures. After 3 days of culture, labelled EVs from all three cell sources were visible inside the AT-MSCs (Fig. 5B-D) . To exclude that DiD micelles or other background staining would be mistaken for EVs, EV-free PBS was stained with DiD and processed the same way. No background staining was visible under the confocal microscope when the cells had been incubated with the control (Fig. 5A) .
The interaction between AT-MSCs and MC-EVs and OC-EVs was confirmed by flow cytometry analysis ( Fig. 5E-G Incomplete osteoclast formation (D) and intact HA coating (H) was observed at 5 days of osteoclast differentiation. Medium was changed to medium depleted of EVs when osteoclasts had formed (E,I). Osteoclast-conditioned medium was collected 3 days (F,J) and 5 days (G,K) after changing to EV-depleted medium. Scale bar: 100 lm.
detected, defined as the fraction of the cells with a fluoresence higher than greater than that of 95% of ATMSCs incubated with the DiD-labelled control.
Microarray analysis of gene expression by ATMSCs cultured in the presence of monocyte-and osteoclast-derived EVs
The effect of the MC-EVs and OC-EVs on gene expression patterns in AT-MSCs was analysed using microarrays. AT-MSCs were exposed to equal numbers of MC-EVs or OC-EVs for a period of 18 days. The EVs had been isolated from the conditioned media using the isolation kit. AT-MSCs cultured in EV-depleted maintenance medium (MM) was the reference condition. Because gene expression patterns related to osteoblast differentiation and bone remodelling were of interest in this study, we also included AT-MSCs cultured in established osteogenic culture conditions (osteogenic differentiation medium, ODM). A total of 3187 genes were found to be differentially expressed between the culture conditions (false discovery rate < 0.05; Figs 6 and 7). We performed direct quantification of nine selected gene transcripts by quantitative PCR (qPCR) to validate the microarray findings (Fig. 8) . The qPCR analysis was performed separately for each of the six donor replicates. In every case, a strong correspondence between the microarray and qPCR data was observed. Figure 6 shows a heatmap of the genes that were differentially expressed between the culture conditions. Gene expression patterns of samples cultured in ODM were most distinct from those in other conditions. However, ODM did not result in a gene expression pattern typical of (differentiating) osteoblasts. Osteogenic marker genes like RUNX2 or ALPL stayed at similar or even slightly lower levels, although not significant. Expression of BMP2, which plays an important role in bone development, was even substantially downregulated in ODM. When the microarray results were validated by qPCR, BMP2 expression levels were significantly lower in ODM compared to MM (Fig. 8) .
The gene expression patterns of cells from donor pool was similar when these cells had been exposed to OC TCPS-EVs, OC HA-EVs or when cultured in MM without EVs (Fig. 6) . The gene expression patterns were more similar between these conditions than with other donor pools in the same culture condition. This reflects the similarity between these conditions and the limited effect of OC-EVs on gene expression patterns in AT-MSCs. Exposure to either OC TCPS-EVs or OC HA-EVs, did not lead to significant regulation of genes relative to EV-depleted MM (Fig. 7) .
Stimulation with MC-EVs on the other hand resulted in 176 upregulated genes and 251 downregulated genes compared to EV-depleted MM (Fig. 7) . Samples exposed to MC-EVs show great similarity among the different donor pools (Fig. 6) . Genes that were differentially expressed in the presence of MC-EVs showed great overlap with genes differentially expressed in established osteogenic induction conditions. Of the 427 genes that were significantly regulated by MC-EVs, 211 were also differentially expressed in ODM. The direction of regulation, however, did not necessarily match. Of the 176 genes upregulated by MC-EVs, only 10 were also Genes that were significantly upregulated by MCEVs include many genes encoding for cytokines (Fig. 9 ). More specifically, CXC chemokines, such as CXCL5 and CXCL3, and interleukin 1 (IL-1) cytokines, such as IL1RN and IL1B were expressed at higher levels. In addition, exposure to MC-EVs led to expression levels of matrix metalloproteinases, such as MMP3 and MMP1.
To characterize the function of the genes upregulated by MC-EVs, an enrichment analysis of the genes was performed by their functional annotation with gene ontology (Fig. 10) . Gene ontology terms for biological processes reflecting the function of cytokines, such as regulation of cell motility, positive regulation of cell migration and positive regulation of immune system processes were enriched for genes upregulated by MCEVs. Gene ontology terms for molecular functions exerted by cytokines and chemokines in particular were enriched, as well as the binding of receptors for CXCR chemokines and IL-1 molecules. Enrichment of the gene ontology term for metalloendopeptidase activity reflects the increased expression levels of matrix metalloproteinases.
Biochemical analysis of AT-MSCs cultured in the presence of monocyte-and osteoclast-derived EVs
Quantification of alkaline phosphatase activity was employed to evaluate the effect of MC-EVs or OC-EVs on the early osteogenic differentiation of AT-MSCs (Fig. 11) . The observed effect of established osteogenic conditions was only small. Exposure to MC-EVs led to a slightly bigger increase in alkaline phosphatase activity. We did not observe an effect of OC TCPS-EVs or OC HA-EVs on alkaline phosphatase activity.
Total collagen production was evaluated by quantification of hydroxyproline content in the cell lysate. ODM induced a small median increase in collagen production compared to EV-depleted MM. Collagen content had increased substantially under OC HA-EVs stimulation for some samples. The effect from MCEVs was more consistent among the different donor replicates causing a median 2-fold increase in collagen content. We observed a slight decrease in collagen content when OC TCPS-EVs were used to stimulate ATMSCs.
According to Kruskal-Wallis one-way analysis of variance by ranks, alkaline phosphatase activity and collagen content were not equal in all conditions (P = 0.021 and P = 0.0098, respectively). 
Gene expression and protein secretion by ATMSCs and BM-MSCs cultured in the presence of monocyte-and osteoclast-derived EVs
Next, we assessed the difference between MSCs isolated from adipose tissues and BM with respect to their response to MC-and OC-EVs. LPS was added to both MCs and OCs before the conditioned medium was collected. EVs were isolated by UC. To control for the effect of particles coprecipitated with the EVs, we supplemented the MSC culture medium with UC precipitate from LPS-activation medium (UC LPS) and LPS-supplemented osteoclast differentiation medium (UC OCDM) that had not been in touch with cells. After culturing the AT-MSCs and BM-MSCs in the presence of the EVs and controls without EVs, we analysed gene expression using qPCR (Fig. 12 ). Genes were chosen because of their relevance in osteoblast differentiation or because they had been found differentially expressed in MC-EV-stimulated ATMSCs in our microarrays. In addition, we assessed the secretion of cytokines and soluble intercellular adhesion molecule 1 (ICAM-1) at protein level (Fig. 13) .
These experiments confirmed in large the results obtained from the microarrays. Expression of CXCL5 was increased in the presence of MC-EVs for both AT-MSCs and BM-MSCs (Fig. 12A ). The difference with UC LPS was statistically significant for BMMSCs. MMP1 expression levels were also slightly increased in AT-MSCs in response to MC-EVs (Fig. 12B ). We did not detect differences in MMP1 expression levels in BM-MSCs in response to EVs. MMP1 expression by BM-MSCs was substantially decreased when BM-MSCs were cultured in ODM. Culture in ODM slightly decreased expression levels of ICAM1 in AT-MSCs (Fig. 12C ), confirming our previous observation (Fig. 8F) . In BM-MSCs on the other hand, ICAM1 was expressed at significantly higher levels in ODM than in MM. ICAM1 expression was higher in the presence of EVs than in MM for both MSC types, but a similar effect was seen in AT-MSCs when cultured with UC precipitate without EVs. Stimulation of BM-MSCs with MC-EVs and OC TCPSEVs caused a substantial increase in expression of ICAM1 compared to the controls without EVs. Expression of osteogenic marker genes ALPL and RUNX2 were not affected by our experimental conditions ( Fig. 12D ,E). BM-MSCs expressed RUNX2 at higher levels than AT-MSCs. Monocyte-EVs stimulated the secretion of cytokines by AT-MSCs, confirming our microarray results ( Fig. 13A-C) . MC-EVs also increased cytokine secretion by BM-MSCs, although the effect was less apparent than for AT-MSCs. Due to the high variability between the three donor repeats, no statistically significant differences were found between the protein 1.00e+00
Relative ACAN expression B 2.5e−01
1.0e+00
Relative ALPL expression C * 2.5e−01
4.0e+00
6.25e−02
2.50e−01
2.00e+00
1.60e+01 secretion by MSC-EV-stimulated AT-MSCs and the control (UC LPS). The conditioned medium from MSCs cultured with OC TCPS-EVs also contained slightly elevated levels of cytokines. The chemokines CCL2 (chemokine [C-C motif] ligand 2) and IL8 were already present in the OC TCPS-EV-supplemented medium. Chemokines CCL5, chemokine [C-X-C motif] ligand 9 (CXCL9) and CXCL10 were not detected by the human chemokine kit. Mesenchymal stem/stromal cells secreted soluble ICAM-1 in response to MC-EVs and OC-EVs (Fig. 13D) . ICAM-1 secretion in response to the EVs showed similarities with cytokine secretion. AT-MSCs secreted the most ICAM-1 in response to MC-EVs, just like we observed for cytokines. Highest ICAM-1 concentrations in BM-MSC-conditioned medium were measured from cultures with OC-TCPS-EVs, but like cytokines, soluble ICAM-1 was already present in the OC TCPS-EV-supplemented medium before MSCs were cultured.
Discussion
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We compared the effects of EVs from LPS-activated MCs and OCs at a genome-wide scale. Unlabelled MCs were obtained by depletion of non-MCs using a cocktail of antibody-conjugated microbeads. Positive selection of CD14+ MCs using anti-CD14 microbeads would block CD14, which functions as a receptor for LPS [21] . This would lead to an inability of the MCs to be activated by LPS stimulation, which is thought to lead to more profound and prolonged osteoinductive signalling to MSCs [22] . When experiments were repeated, we also added LPS to the OC cultures to make comparison between the effects of MC-EVs and OC-EVs more straightforward. We hypothesized that EVs represent a part of the osteoinductive signals from OCs to MSCs that depends on the resorption activity 
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EV isolation method affected EV yield, but did not change the response in MSCs
We used a kit to isolate the EVs from the cellconditioned medium for the microarray experiments. The isolation kit works by lowering the hydration of the EVs, thereby reducing their solubility and allowing precipitation of the EVs at lower centrifugal forces. The main advantage of this type of kits is the ability to isolate EVs from a large volume of conditioned medium in a relatively short period of time. However, these kits usually give lower purity than e.g. UC, as the solubility of almost all particles decreases equally [23] . When we repeated the experiments and included BM-MSCs exposed to the EVs, we had isolated the EVs by UC. The particle yield in the UC precipitate was much lower than in the kit's isolate ( Fig. 3 and Table 1 ). It is possible that most particles isolated using the kit were not EVs. Nevertheless, experiments using kit isolates and using EVs obtained by UC lead to similar results. We included EV-free controls for UC and obtained relatively high background levels. The effects of coprecipitated particles on gene expression and cytokine secretion by MSCs, though, were still minor compared to the effects of the EVs, especially MC-EVs. More EVs were obtained from OCs on TCPS, with the exception of blood donor 4. The higher yield from OCs on TCPS than on the HA coatings could be explained by better attachment of the cells on TCPS, resulting in higher cell proliferation than on HA. Consequently, more cells were available to produce EVs.
EV isolates were enriched in exosomes and were free of cell debris
Detection and characterization of EVs in a standardized manner have proven difficult [24] . EV are therefore often characterized using a combination of methods. We identified EVs based on their size, presence of proteins and their biological activity according to the minimal criteria parameters recommended by the International Society of EVs [25] . Overall, morphology and size distribution of the particles indicated an enrichment in exosomes, EVs of endosomal origin between 40 and 100 nm in diameter [26] .
The presence of CD90 argues for the presence of membrane in the isolate and is a general EV marker [25] (Fig. 4) . EVs can bear Hsp70 when they are exposed to stress conditions [27] , and could be upregulated upon LPS stimulation [28] . The presence of TSG101 is more specific for exosomes: TSG101 is required for the sorting of cargo into exosomes [29] . Interestingly, there was a strong signal from tetraspanin CD63 in OC-EVs, while it was almost absent in MC-EVs. Tetraspanins are widely used as exosome markers, because of their role in biogenesis, assembly, and sorting of protein and genetic material into exosomes [27] . Our other results do, however, not suggest a shift in EV population from microvesicles to exosomes when MCs differentiate towards OCs. This shows the difficulty in finding common EV/exosome marker proteins for EVs derived from different cell types, even if those cells stem from the same population.
Monocyte-EVs and OC-EVs were both positive for CD14, reflecting the cell membrane of the MC and shows that CD14 is still expressed on the EV surface once MCs have differentiated into OCs. In accordance with Huynh et al. [30] , we detected RANK in the EVs from mature OCs. The RANK-rich EVs may function by competing with RANK+ OC precursors for RANKL, thereby inhibiting their own formation [30] . The MC-EVs also expressed RANK, contrary with the previously reported RANK-negative EVs from primary mouse marrow-derived OC precursors [30] . This shows that precursor cells derived from different tissues and animals might differ in the EVs they produce and the way these EVs function in regulating differentiation.
As mentioned above, impurities in the samples might affect the results. We can rule out major contaminations consisting of cell debris, because endoplasmic reticulum protein calnexin was absent.
Isolated monocyte-and osteoclast-derived EVs were functional and adipose tissue-derived MSCs are one of their targets
Apart from sample purity, it is important that the isolated EVs are functional. Our results show that the and BM-MSCs (blue fill). MSCs were cultured in EV-free MM, ODM or exposed to MC-EVs, OC TCPS-EVs or OC HA-EVs. In addition, MSCs were cultured in MM supplemented with UC LPS or UC OCDM. Gene expression levels (log2 scale) are shown relative to the median gene expression in MM. Pink and blue bars indicate median expression for AT-MSCs and BM-MSCs, respectively. *False discovery rate-controlled P-value < 0.05, based on paired t-tests for CXCL5 expression in BM-MSCs between MC-EVs and UC LPS (A) and for ICAM1 expression in BM-MSCs between ODM and MM (C).
isolated EVs were able to interact with target cells: ATMSCs took up both MC-EVs and OC-EVs (Fig. 5) . The same was previously found for BM-MSCs that took up EVs from LPS-activated MCs [20] ) and dendritic cells [31] , another mononuclear phagocytic cell type. These results suggest that many, if not all, mononuclear phagocytes interact with MSCs through their EVs. The EVs were found in clusters close to the nuclei, suggesting active endocytosis of the EVs leading to processing of their molecular cargo [31] . Other mechanisms of interaction with the AT-MSCs cannot be ruled out, such as EV-mediated activation of membrane-bound receptors that trigger signalling pathways, or fusion with the cell membrane leading to release of the EV cargo into the cell cytoplasm [24] . Ekstr€ om et al. [20] found that uptake of MC-EVs by BM-MSCs differed largely between cells within the same culture and also between different experiments. Uptake of EVs could be affected by proliferation status and membrane composition [20] . Differences in uptake efficiency between the EVs of different origin were not the main interest of this study and would require a different experimental set-up. Conclusions EV-MSC interaction based on different numbers of DiD-labelled EVs inside the AT-MSCs (Fig. 5A-D) or on EV-positive AT-MSC fractions (Fig. 5E-G) should therefore be taken with care.
Isolated monocyte-and osteoclast-derived EVs carry different signals to MSCs
Current scientific literature is not unanimous about the effects of EVs derived from mononuclear phagocytes on MSCs. EV derived from LPS-activated MCs were reported to stimulate osteogenic differentiation of MSCs [20] and similar results have been reported for dendritic-cell derived EVs [32] . Silva et al. [31] on the other hand did not find any effects of dendritic-cell derived EVs on osteogenic differentiation, despite the accumulation of these EV inside the MSCs. Also the interactions between OCs, osteoblasts and mesenchymal precursors partially take place through tranfer of EVs. These interactions can also inhibit osteoblast activity, as OC-EVs are able to transfer miR-214-3p to inhibit osteoblast activity in vitro and reduce bone formation in vivo [33, 34] .
In the present study, we did not observe a significant effect of OC-EVs on gene expression in MSCs (Fig. 7) . We chose to culture the AT-MSCs in equal numbers of MC-and OC-EVs in the microarray experiments, in order to compare their potency to change AT-MSC gene expression. When we analysed gene expression and protein secretion by AT-MSCs and BM-MSCs, we used EVs isolated from the same volume of conditioned medium so that they came from cultures with the same number of initially seeded MCs. OC-EVs did not have or had a smaller effect than MC-EVs, at least for the genes and proteins that we analysed (Figs 12  and 13 ). We cannot exclude that OC-EVs trigger signalling pathways different from the ones activated by MC-EVs, but that we would only detect if we had used more EVs. Characterizing the molecular cargo carried by MC-EVs and OC-EVs would provide insight in how the regulating potential of EVs changes when MCs differentiate into OCs.
Monocyte-derived EVs promote the secretion of various cytokines in MSCs, representing an immunomodulatory mechanism
Mesenchymal stem/stromal cells interact with the immune system by secreting anti-inflammatory factors, as well as by expressing cell surface molecules that suppress the maturation, activation and function of immune cells [35] . Their immunosuppressive properties make MSCs a relevant cell source when considering immunomodulation therapies and allogeneic stem cell treatments [36] . The immunosuppressive effects of MSCs are at least partially mediated by EVs [37] . Here, we show that MC-EVs upregulated the secretion of various cytokines by MSCs. Chemokine secretion by MSCs may represent an immunomodulatory mechanism in which chemotaxis brings specific immune cell subsets in close proximity to MSCs, which makes them more susceptible for the immunosuppressive actions of MSCs [38, 39] . The response to MC-EVs was stronger in AT-MSCs than in BM-MSCs, reflecting the greater immunomodulatory potency of AT-MSCs [36] .
Exposing MSCs to the UC precipitate of unconditioned LPS-supplemented medium (UC LPS and UC OCDM) did not affect gene expression nor protein secretion, except for ICAM1 expression and the secretion of its protein product in AT-MSCs. We suspect that traces of LPS in the UC precipitate upregulated the expression of ICAM1. Upregulation of ICAM1 in response to LPS has been long known in epithelial cells [40] [41] [42] , but has so far not been reported in MSCs. LPS can suppress the osteogenic differentiation potential of MSCs through the Toll-like receptor 4 mediated nuclear factor jB pathway [43] . The differentiation potential of BM-MSCs, however, is not affected by LPS, showing that the response to LPS is dependent on the tissue source of the MSCs [43] . Likewise, in the present study, ICAM1 expression in BMMSCs was not affected by UC LPS and UC OCDM. Addition of EVs did not lead to differential expression of ICAM1 compared to the aforementioned controls.
Monocyte-derived EVs upregulated expression of MMPs and might drive tissue remodelling processes
After OCs have finished resorbing a packet of bone, collagen fibrils are left in the resorption pit that protrude from the bone surface. The collagen fibrils need to be removed before new bone formation can take place [44] . It has long been unknown which cells are responsible for the removal of these collagen fibrils. Given that mononuclear cells (lymphocytes and MCs) reside near the bone surface, it has been suggested that mononuclear phagocytes are involved in their removal [45] . Our data confirm that MCs might play a role by stimulating collagen removal through EV-mediated signalling. MC-EVs upregulated the expression of MMPs, thereby stimulating processes related to the reorganization of the extracellular matrix structure, in particular the removal of collagens. We show that MMPs are overexpressed in MSCs, suggesting that cells of mesencymal lineages start to remove collagens in response to the presence and activation of MCs. These results confirm the suggestion that bone lining cells clean the bone surface before new bone formation takes place [44] . Bone lining cells are mesenchymal cells and although bone lining cells do not form bone, they belong to the same lineage as osteoblasts. Although speculative, signals from MCs, combining both soluble factors and MC-EV interactions, may direct MSCs to differentiate towards bone lining cells.
Our results show the importance of EV-mediated signalling between MCs and MSCs for controlling the function of the immune system. The promotion of cytokine secretion by MC-EVs may enhance the immunosuppressive actions of the MSCs. EV-mediated signalling might represent an additional mode of intercellular communication during the transition from injury and inflammation to bone regeneration. The upregulation of MMPs suggests an important role of MC-EVs in the coupling between bone resorption and bone formation. Characterizing the molecular cargo carried by MC-EVs and OC-EVs would provide insight in how the regulating potential changes of the EVs when MCs differentiate into OCs.
Conclusion
Our results show the importance of EV-mediated signalling between MCs and MSCs for controlling the function of the immune system. MC-EVs promoted the secretion of various cytokines by MSCs. Chemokine secretion by MSCs may represent an immunomodulatory mechanism in which chemotaxis brings specific immune cell subsets in close proximity to MSCs, which makes them more susceptible for the immunosuppressive actions of MSCs. MC-EVs form promising prospects for the development of MSC-based immune therapy by enhancing the immunosuppressive actions of the MSCs.
Monocyte-EVs upregulated the expression of MMPs, thereby stimulating processes related to the reorganization of the extracellular matrix structure. Signals secreted by MCs may direct MSCs to differentiate towards bone lining cells. EV-mediated signalling might represent an additional mode of cell-cell signalling during the transition from injury and inflammation to bone regeneration and play an important role in the coupling between bone resorption and bone formation.
In the present study, we did not observe a significant effect of OC-EVs on gene expression in MSCs. We cannot exclude that OC-EVs trigger signalling pathways different from the ones activated by MC-EVs. Characterizing the molecular cargo carried by MCEVs and OC-EVs would provide insight in how the regulating potential changes of the EVs when MCs differentiate into OCs.
Material and methods
Preparation of hydroxyapatite coatings in 24-well culture plates
Hydroxyapatite coatings were deposited in 24-well culture plates in a two-step procedure consisting of precalcification and crystal growth as described by Patntirapong et al. [18] . The 24-wells were precalcified using a 3 9 concentrated simulated body fluid (SBF 9 3) into each well. SBF 9 3 was prepared by mixing calcium solution (820 mM NaCl, 8.9 mM MgCl 2 Á6H 2 O, 105 mM CaCl 2 Á2H 2 O) and phosphate solution (25 mM NaHCO 3 , 1.9 mM NaHPO 4 Á2H 2 O), both of which were prepared in 50 mM Tris HCl buffer solution at pH 7.4. Freshly prepared SBF 9 3 solution was added to each well (1.5 mL) and refreshed daily during a 3-day incubation period at room temperature. This resulted in the formation of a thin amorphous calcium phosphate coating that acted as nucleation layer for crystal growth in the second step. At the end of the precalcification, the wells were thoroughly washed in distilled H 2 O and dried at 50°C.
In the second step, calcium phosphate solution was prepared by dissolving 140 mM NaCl, 4 mM CaCl 2 Á2H 2 O and 2.6 mM NaHPO 4 Á2H 2 O in 50 mM Tris HCl buffer at pH 7.4. Calcium phosphate solution was added to the precalcified wells (1.5 mL) and refreshed daily during a 3-day incubation period at room temperature. The resulting HA coatings resemble the mineral component of bone. The HA coated wells were thoroughly washed in distilled H 2 O and dried at 50°C. Before use for cell cultures, the wells were sterilized by soaking in 70% ethanol and drying under ultraviolet light for 20 min.
Isolation of human monocytes
Human buffy coats were obtained from the Finnish Red Cross Blood Service (Helsinki, Finland). Buffy coats were left from the processing of blood collected from healthy voluntary blood donors. Before blood donation, donors are informed that blood samples that are not required for patient treatment can be used anonymously for research work. The use of buffy coats for this project was approved by the ethical committee of the Finnish Red Cross Blood Service. The study methodologies conformed to the standards set by the Declaration of Helsinki.
Monocytes were isolated from 40 mL of buffy coat in a two-step procedure [46] . Briefly, peripheral blood mononuclear cells (PBMCs) were extracted from the buffy coats by gradient centrifugation. The buffy coat was diluted 1 : 1 with PBS and gently layered on top of Lymphoprep TM (StemCell Technologies, Vancouver, Canada). The gradient was centrifuged for 30 min at 800 g with the brake off. The PBMC layer was collected and washed several times with PBS.
Monocytes were isolated from the PBMC fraction by depletion of non-MCs (negative selection) using a MC Isolation kit II (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer's instructions. Briefly, non-MCs were indirectly magnetically labelled with a cocktail of biotin-conjugated monoclonal antibodies against CD3, CD7, CD16, CD19, CD56, CD123 and Glycophorin A. Anti-biotin monoclonal antibodies conjugated to microbeads were used to magnetically label non-MCs which were then retained in a magnetic field.
Culture of monocytes and generation of osteoclasts
Monocytes were plated at a density of 1.5 9 10 5 cellsÁcm À2 in 24-well plates, either on TCPS or coatings of HA. MCs were either activated by culturing in MM supplemented with 10 ngÁmL À1 LPS (LPS-activation medium, Table 2 ) or stimulated to generate OCs in OCDM ( Table 2 ). The cells were cultured at 37°C and 5% CO 2 in a humidified atmosphere. The culture medium was refreshed every 2-3 days. LPS-activated MCs were cultured in EV-depleted medium from the start of the culture. The OC differentiation cultures were changed to EV-depleted OCDM once OCs had formed. EV-depleted OCDM was supplemented with LPS for the culture of cells from blood donors 3 and 4. EVdepleted medium was prepared with FBS depleted of EVs by UC for 19 h at 120 000 g (26 000 r.p.m. in an Optima LE-80K ultracentrifuge equipped with an SW-28 swingingbucket rotor, Beckman Coulter, Inc., Brea, CA, USA). At the beginning of the conditioned medium collection, samples were taken by fixing of the cells in 4% paraformaldehyde (Sigma-Aldrich, Saint Louis, MO, USA). To confirm the formation of OCs, the cells were stained for IC-specific marker TRAcP using the Leucocyte acid phosphatase kit (Sigma-Aldrich) according to the manufacturer's instructions. During the culture and after the staining, cells were monitored and imaged using a Nikon Eclipse TS100 inverted phase-contrast microscope (Nikon Corporation, Tokyo, Japan) equipped with a Nikon DS-Fi2 camera.
Collection of monocyte-and osteoclast-condition medium and isolation of extracellular vesicles
The conditioned medium was collected from the LPS-activated MCs at 3 and 5 days of culture. The conditioned medium from OCs was collected 3 days and 5 days after changing to EV-depleted medium. The conditioned medium was depleted of cell debris by centrifuging for 20 min at 2500 g and the supernatant was filtered through a 0.45 lm sterile filter (Merck, Darmstadt, Germany).
For blood donors 1 and 2, EVs were isolated from the conditioned medium using an isolation kit. The miR-CURY TM Exosome Isolation Kit (Exiqon A/S, Vedbaek, Denmark) was used according to the manufacturer's instructions. Briefly, hydration of particles was diminished by mixing the media with the precipitation buffer provided in the kit. After incubation at 4°C for minimally 1 h, the EVs were precipitated by centrifugation at 3000 g for 30 min. The supernatant was removed and the pellet was resuspended in the resuspension buffer provided in the kit. EVs were stored at À75°C until further use.
For blood donor 3 and 4, EVs were isolated from the conditioned medium by UC for 2 h at 120 000 g. The UC precipitate was washed by adding a large volume of filtered PBS (0.1 lm filter), after which UC was repeated. EVs were resuspended in filtered PBS and stored at À75°C until further use.
Characterization of monocyte-and osteoclastderived extracellular vesicles
Monocyte-EVs, OC TCPS-EVs or OC HA-EVs were characterized using transmisssion electron microscopy, nanoparticle tracking analysis and western blotting. Extracellular vesicles were washed by diluting in PBS and ultracentrifuged for 2 h at 120 000 g. The EV samples were resuspended in PBS and prepared for transmisssion electron microscopy as described previously [47] . After loading to 200 mesh copper grids and fixation with 2% paraformaldehyde in 0.1 M NaPO 4 buffer (pH 7.0), samples were washed with the 0.1 M NaPO 4 buffer and deionized water, negatively stained with 2% neutral uranyl acetate and embedded in methyl cellulose uranyl acetate mixture (1.8/0.4%). Samples were viewed with transmisssion electron microscopy using Tecnai 12 (FEI Company, Eindhoven, the Netherlands) operating at 80 kV. Images were taken with Gatan Orius SC 1000B CCD-camera (Gatan Inc., Pleasanton, CA, USA) with 4008 9 2672 px image size and no binning.
Nanoparticle tracking analysis was used to quantify and determine the size distribution of particles in the EV samples. EV samples were diluted in PBS and injected into the NanoSight LM14 (NanoSight Ltd., Salisbury, UK) equipped with a blue laser (405 nm, 60 mW) and a sCMOS camera. Three videos of 60 s (1498 frames each) were recorded and analysed using NANOSIGHT software v3.0 (Particular Sciences Ltd, Dublin, Ireland). Particles between 50 and 400 nm in diameter were considered EVs.
Western blotting was performed as described previously [47] . The following antibodies were used: mouse anti-Thy1 (CD90; Sigma-Aldrich, clone 3F9, 1 : 500), rabbit anti-TSG101 (Sigma-Aldrich, polyclonal, SKU HPA006161, 1 : 500), mouse anti-Hsp70 (BD Biosciences, Becton Dickinson, Franklin Lakes, NJ, USA, clone 5G10, 1 : 1000), mouse anti-CD63, (BD Biosciences, clone H5C6, 1 : 1000), mouse anti-CD14 (R&D systems, Minneapolis, MN, USA, clone 134603, 1 : 1000), mouse anti-RANK (receptor activator of nuclear factor the conditioned medium using an j-B; Novus Biologicals, Littleton, CO, USA, clone 9A725, 1 : 1000) and rabbit anti-calnexin (Cell Signaling Technology, Leiden, the Netherlands, clone C5C9, 1 : 800). EVs were isolated by UC from equal volumes of conditioned medium and loaded to the gel. Protein from MC lysate was loaded to the gels as a control. EV samples were denatured at 95°C for 5 min in reducing Laemmli sample buffer, separated using Mini-PROTEANÒ TGX TM 4-20% gradient SDS/PAGE gels (Bio-Rad, Hercules, CA, USA) with page ruler prestained protein ladder (Thermo Fisher Scientific, Waltham, MA, USA) as a standard and blotted on Immobilon-P poly(vinylidene difluoride) membrane (Merck). Blocking and antibody incubations were performed in Odyssey blocking buffer (LI-COR BioSciences, Lincoln, NE, USA) without and with 0.1% Tween-20, respectively. Membranes were subsequently probed with IRDyeÒ 800CW Goat anti-Mouse (LI-COR) at 1 : 15 000 for 2 h at room temperature. After incubation, membranes were washed three times in TBS-T for 10 min at room temperature and imaged on an Odyssey FC Imager (LI-COR). Anti-CD63 was applied to nonreduced samples.
We have submitted all relevant data of our EV experiments to the EV-TRACK knowledgebase (EV-TRACK ID: EV170018) [48] .
Isolation and characterization of adipose tissuederived and bone marrow-derived mesenchymal stem/stromal cells The use of human MSCs confirmed to the standards set by the Declaration of Helsinki.
Human AT-MSCs were obtained from water-assisted lipotransfer liposuction aspirates [49] from nine female donors (median age 44.5, range: 32-60) using mechanical and enzymatic isolation as described previously [50] . The study was carried out under approval of the ethical committee of Helsinki and Uusimaa Hospital District and with informed consent from the donors.
Human BM-MSCs were isolated as described previously with slight modifications [51] . BM was obtained under approval of the ethical committee of the Pirkanmaa Hospital District (R15174) and the written consent of the patients. The BM was diluted 1 : 3 with Dulbecco's PBS (GibcoÒ; Thermo Fisher Scientific). The mixture was layered on a Histo Paque-1077 (Sigma-Aldrich) cushion and centrifuged at 800 g for 20 min at room temperature. Mononuclear cells were collected from the liquid interface and washed with aMEM (Lonza, Basel, Switzerland).
The MSCs were expanded in MM (Table 2 ) at 37°C and 5% CO 2 in a humidified atmosphere.
After expansion, MSCs were characterized using a BD Accuri TM C6 flow cytometer (Becton Dickinson) to confirm the mesenchymal origin of the cells. We used monoclonal antibodies conjugated with allophycocyanin against CD14 (clone M5E2 and CD105 (endoglin) and no or low expression of CD14 (MC and macrophage marker), CD19 (dendritic cell marker), CD45 (pan-leucocyte marker) and HLA-DR (human leucocyte antigen class II; Table 3 ). Moderate expression of CD34 (haemopoetic progenitor cell antigen) and CD54 (ICAM-1) in AT-MSC conforms to previous reports for culture in FBS [52] . The results showed that MSCs expressed most of the specific antigens that define human stem cells of mesenchymal origin according to the criteria set by the Mesenchymal and Tissue Stem Cell Committee of the ISCT [53] .
Uptake of monocyte-and osteoclast-derived EVs by adipose tissue-derived mesenchymal stem/ stromal cells Extracellular vesicles were labelled in 1 lM DiD lipophilic dye (Thermo Fisher Scientific) for 1 h at room temperature. The unbound dye was removed by adding a large volume of PBS and UC for 2 h at 120 000 g. The washing step was performed twice before resuspending the EV pellet in EV-depleted MM. DiD-labelled PBS without EVs was processed the same way to serve as a control. Adipose tissue-MSCs from donor 7 were seeded in 8-well chamber slides (Ibidi GmbH, Planegg, Germany) at passages 4 or 7 and 1 9 10 4 cellsÁcm
À2
. The cells were allowed to attach in MM overnight before the medium was changed to EV-depleted MM supplemented with 3 9 10 9 DiDlabelled EVsÁmL À1 based on nanoparticle tracking analysis (1.5 9 10 5 EVs per cell), or to EV-depleted MM supplemented with the PBS control. After 3 days, the cells were labelled with 5 lM CellTrace TM CFSE dye (Thermo Fisher Scientific) and 1 lgÁmL À1 Hoechst 33342 (Sigma-Aldrich), both for 20 min at 37°C. The cells were washed prior to imaging. Microscopy was performed on a TCS CARS SP8 confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany) with a 639 water immersion objective. After imaging, cells were detached by trypsin treatment and analysed by flow cytometry (BD AccuriÒ C6). DiD fluorescence intensity was detected using the FL4 channel (675/25 nm laser). The data were analysed and visualized using R Statistical Software (R Foundation for Statistical Computing, Vienna, Austria).
Exposure of adipose tissue-derived and bone marrow-derived mesenchymal stem/stromal cells to monocyte-and osteoclast-derived EVs Adipose tissue-MSCs and BM-MSCs were seeded in 96-well plates at passages 4-6 and 2.5 9 10 3 cellsÁcm
. The cells were allowed to attach in MM overnight before the medium was changed to EV-depleted MM supplemented with 3 9 10 9 EVsÁmL À1 based on nanoparticle tracking analysis (6 9 10 5 EVs per cell). Cells cultured in EV-depleted MM and cells cultured in EV-depleted ODM (Table 2) were used as controls. In addition, we supplementing the MSC culture medium with UC precipitate from LPS-activation medium (UC LPS) and LPS-supplemented OCDM (UC OCDM) that had not been in with cells, to control for the effect of particles from the culture media coprecipitated with the EVs. The cells were cultured at 37°C and 5% CO 2 in a humidified atmosphere for 18 days or 19 days, during which the medium was refreshed every 2-3 days. Each time, EVs were freshly added. At the end of the culture, the wells were washed in PBS and the contents were collected for analysis. For analysis of protein secretion, the MSC-conditioned medium was collected, depleted of cell debris by centrifuging for 20 min at 2500 g and stored at À75°C until further use.
Gene expression analyses by microarrays and quantitative PCR
Total RNA was isolated from MSCs using the miRCUR-Y TM RNA Isolation Kit (Exiqon A/S) according to the manufacturer's instructions. Concentration and purity of RNA was measured with the Agilent 2200 TapeStation (Agilent Technologies, Foster City, CA, USA) or NanoDrop-1000 (Thermo Fisher Scientific).
For the microarray analysis, the RNA from 5 AT-MSC donors (donor 1-5) was pooled into three distinct pools per condition. The starting amount of total RNA was 100 ng. cDNA was generated using GeneChipÒ WT Plus Reagent Kit (Affymetrix, Inc., Santa Clara, CA, USA). Micorarray analysis was performed using Clariom D Human Arrays (Affymetrix), which contain 135 750 human gene probes. Moderated paired t-tests were performed using the limma package in R based on Bayesian statistics and fitting of data to a linear model [54] . A false discovery rate of < 0.05 was used to filter differentially expressed genes between treatments and control (EV-depleted MM). A heat map was generated using the expression values of differentially were considered significant when the false discovery ratecontrolled P-value was below 0.05.
